PhaseBio Pharmaceuticals Inc·4

Nov 3, 7:30 PM ET

Mow Jonathan P 4

4 · PhaseBio Pharmaceuticals Inc · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-03
Mow Jonathan P
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-03$1.24/sh+20,000$24,800166,850 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-11-03$1.24/sh20,000$24,800108,767 total
    Exercise: $1.24From: 2018-10-08Exp: 2024-11-04Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]All shares underlying this option have vested.

Documents

1 file
  • 4
    wf-form4_163598223753695.xmlPrimary

    FORM 4